Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
about
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology GroupHigh transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.Disparities in cancer outcomes: lessons learned from children with cancerOutcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.
P2860
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@ast
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@en
type
label
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@ast
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@en
prefLabel
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@ast
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@en
P2093
P1476
Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
@en
P2093
Franklin O Smith
Robert J Arceci
Soheil Meshinchi
P2888
P304
P356
10.1007/S11912-003-0010-1
P577
2003-11-01T00:00:00Z